Abstract:Thrombophilia, also known as hypercoagulability or prothrombotic condition, typically arises from an imbalance that occurs either in the coagulation pathway or in the anticoagulation/fibrinolytic system due to various hereditary or acquired factors.[1] Thrombophilia can be associated with deficiencies of natural anticoagulants (antithrombin, protein C [PC], and protein S), elevated homocysteine values, and elevations or other changes in fibrinogen and coagulation factors. Conversely, acquired thrombophilia occurs as a result of secondary diseases, such as autoimmune disorders (antiphospholipid syndrome), trauma, or malignancy.[2] [3] The main clinical manifestations of thrombophilia are venous thromboembolism (VTE), such as deep vein thrombosis, pulmonary embolism, intracranial vein thrombosis, portal vein thrombosis, mesenteric vein thrombosis, etc. Certain types of thrombophilia can be manifested as acute coronary syndromes, ischemic stroke, and other arterial thrombotic events.[4] Hereditary thrombophilia is typically autosomal-dominant and has a reported population prevalence of approximately 7%; patients with hereditary thrombophilia can have a risk of VTE that is 3 to 20 times greater than that of the general population.[5] Genetic testing is conducive to confirming the diagnosis of hereditary thrombophilia in families with a known mutation. We report an interesting case of hereditary thrombophilia in a patient who harbored a PROC gene mutation. A 68-year-old elderly female with coronary atherosclerosis and type 2 diabetes presented to the local hospital with recurrent episodes of chest tightness and chest pain while visiting Tibet. She was found to have diminished oxygen saturation (sO2 84%), increased D-dimer (1.64 mg/L, reference A2. The joints were normal, with marked edema of the left lower extremity. Laboratory examination: D-dimer 2.258 mg/L, PC activity assay: 59% (reference range: 70–140%). Doppler echocardiography demonstrated right ventricular wall thickening, dilatation of the main pulmonary artery, and left ventricular ejection fraction of 62%. Ultrasound of the deep veins of the left lower limb demonstrated thrombosis, and computed tomography of pulmonary arteries (CTPA) suggested multiple pulmonary emboli in both lungs with decreased perfusion in the corresponding areas ([Figs. 1] and [2]). We hypothesized that the patient's condition was not characterized by an acute onset, and the severity of the symptoms was not as pronounced as initially anticipated. Given the patient's family history of thrombosis, we also performed the Thrombosis and Hemostasis Gene Panel test, revealing that there was a point mutation in the PROC gene ( PROC : NM_001375607;exon5:c.561_576dup:p.E196Pfs*33) that would lead to a defect in PC function and an enhanced risk of thrombosis. The diagnosis of hereditary thrombophilia was thus confirmed, even though there were additional risk factors—the patient's advanced age, long-distance travel, and non-O blood group. Following the thorough diagnostic work-up, the patient received subcutaneous injections of enoxaparin sodium 60 mg twice per day. After a 10-day treatment period, a noticeable reduction in the circumference of the patient's left lower limb was observed. The D-dimer levels also declined from 2.258 to 0.804 mg/L. The ultrasound indicated that there was little change in the thrombosis of the deep veins. Following the switch from enoxaparin sodium injection to a daily dose of 20 mg of rivaroxaban, the patient was discharged from the hospital. Nevertheless, sh -Abstract Truncated-

Factor V Leiden Heterozygous: Complicated by Recurrent Venous Thromboembolism and Bilateral Pulmonary Embolism

Homozygous Factor V Leiden Complicated by Heparin-Induced Thrombocytopenia: A Case Report

[Postpartum Fatal Pulmonary Embolism with F5 Gene Mutation: a Case Report].

The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension

Successful Laparoscopic Common Bile Duct Exploration in A Patient with Factor V Deficiency, A Case Report and Review of Literature

Total Hip Arthroplasty in Patients Who Have Factor V Leiden: Elevated Risks Isolated to Venous Thromboembolism Events

Pulmonary embolism in a hemophiliac patient with factor V and VIII deficiency: a case report

A Rare Case of Left Ventricular Thrombus in a Normal Heart in a Patient With Factor V Leiden Disease

Total shoulder arthroplasty in patients with Factor V Leiden

Double-heterozygous FVL/PTGM: double the trouble

Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys

Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis

Thrombosis Risk in Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A in FinnGen and the UK Biobank

Combined Thrombophilic Risk Factors and Essential Thrombocythemia in Patient with Recurrent Venous Thromboembolic Episodes—Thirty-Three-Year Follow-Up

Hereditary Thrombophilia: A Case of Subacute Pulmonary Embolism in a 68-Year-Old Female with a Mutation in the PROC Gene

Acquired Factor V Inhibitor with Lupus-Like Features

Multiple venous thrombosis caused by F9 gene duplication and treated with catheter-directed thrombolysis, AngioJet-assisted pharmaco-mechanical thromboectomy and manual aspiration thromboectomy

Venous thromboembolism management in people with cystic fibrosis

Missense Mutation of SERPINC1 (p.ser426leu) in a Young Patient Presenting As Refractory and Recurrent Venous Thromboembolism: A Case Report.

Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome

Multiple Arterial and Venous Thromboembolism in a Male Patient with Hereditary Protein C Deficiency: A Case Report.